Skip to main content

California handed its Medicaid drug program to one company. Then came a corporate takeover.

By CaliforniaHealthline  
   April 07, 2022

California awarded the Medi-Cal Rx program to a unit of Magellan Health, a company with expertise in pharmacy benefits and mental health. But Magellan was then gobbled up by industry giant Centene, worth roughly $50 billion, which was looking to expand its mental health portfolio.

Full story


Get the latest on healthcare leadership in your inbox.